logo
  

Medtronic Inc. (MDT) Soared To A New High After Q2 Report

Medtronic Inc. (MDT) reported second quarter adjusted EPS of $0.96 Tuesday morning, up from $0.91 in the prior year period. Analysts expected EPS of $0.96. The company reaffirmed its full year 2015 adjusted EPS guidance of $4.00 to $4.10. The consensus estimate is for EPS of $4.05. Medtronic now forecasts full-year revenue growth in a range of 4 to 5 percent, compared to prior expectations of 3 to 5 percent growth.

Medtronic rose sharply during the first half hour of trade Tuesday and took out the session highs late in the afternoon. The stock ended the day with a gain of 3.28 at $72.47 on above average volume. Medtronic has been climbing for the past month and surged to a new high for the year.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Intelligent Investor.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT